GPD1L and hepatocellular carcinoma: The significant association between high GPD1L mRNA expression and poor clinical outcomes in HCC patients, as well as the independent prognostic significance of GPD1L expression for OS, highlights the potential of GPD1L as a prognostic biomarker in HCC.